NCT05333835: A trial that was reported late by Jiangsu HengRui Medicine Co., Ltd.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT05333835 |
|---|---|
| Title | A 26-week, Randomized, Open-label, 3-arm Parallel, Treat-to-target Study Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin With or Without One Other Oral Anti-diabetic Drug |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 30, 2022 |
| Completion date | March 30, 2024 |
| Required reporting date | March 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 3, 2022 |
| Days late | None |